THOMAS SANDIN: Open Payments
NPI 1356369870 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 29 payments from 11 companies in 2025. Trend: 2023 $953 · 2024 $663 · 2025 $758
Food & beverage: $668Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $162 |
| Regeneron Healthcare Solutions, Inc. | 5 | $140 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| UCB, Inc. | 3 | $76 |
| PFIZER INC. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Lilly USA, LLC | 2 | $48 |
| GENZYME CORPORATION | 2 | $48 |
| Organogenesis Inc. | 1 | $32 |
| Amgen Inc. | 1 | $26 |
Products named: DUPIXENT, TREMFYA, Sotyktu, Bimzelx, CIBINQO, TALTZ, PURAPLY WOUND MATRIX, Otezla.
Industry payments across MI — which companies pay providers there.
